Companies Dominating the Oncology Active Pharmaceutical Ingredient (API) Landscape
- Merck & Co. Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Pfizer Inc.
- Abbott Laboratories
- Sun Pharmaceutical Industries Ltd.
- Novartis AG
- Mylan N.V.
- GSK plc
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Eli Lilli and Company
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of oncology active pharmaceutical ingredient is estimated at USD 2.39 billion.
The oncology active pharmaceutical ingredient market size was over USD 2.14 billion in 2024 and is anticipated to cross USD 5.22 billion by 2037, growing at more than 7.1% CAGR during the forecast period i.e., between 2025-2037. Higher prevalence of cancer across the globe and the mounting geriatric population will drive the market growth.
North America industry is estimated to account for largest revenue share by 2037, impelled by mounting prevalence of cancer.
The major players in the market are Merck & Co. Inc., Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., GSK plc, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Eli Lilli and Company
